Agenzie, enti di riferimento, società scientifiche

• Dipartimento per le politiche antidroga
• EASL, European Association for the Study of the liver
• ECMMDA, European Monitoring Center for Drugs and Drug Addiction
• FeDerSerD Federazione Italiana degli Operatori dei Dipartimenti e dei Servizi delle Dipendenze
• INHSU International Network for Hepatitis in Substance Users
• SIMIT Società Italiana Malattie Infettive e Tropicali
• SIMSPe onlus Società Italiana di Medicina e Sanità Penitenziaria
• SIPaD Società Italiana Patologie da Dipendenza
• The International Society for the Study of Drug Policy
• Osservatorio fumo, droga e alcol Istituto Superiore di sanità
• UNODC United Nations Office on Drugs and Crime

Linee guida di terapia antivirale

• Recommendations for the management of hepatitis C virus infection among people who inject drugs; International Journal of Drug Policy; 2015.
• European Association for the Study of the Liver (EASL): Recommendations on Treatment of Hepatitis C; 2018.
• European Centre for Disease Prevention and Control (ECDC) and European Monitoring Centre for Drugs and Drug Addiction (EMCDDA): Prevention and control of infectious diseases among people who inject drugs; 2011.
• American Association for the Study of Liver Diseases (AASLD) HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C; 2021.
• WHO Guidelines for the screening, care and treatment of persons with hepatitis C infection; 2016.

Linee guida di trattamento delle tossicodipendenze

• American Society of Addiction Medicine (ASAM): National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use; 2015.
• EMCDDA: Guidelines for the treatment of drug dependence: a European perspective; 2011.

Linee guida di riduzione del danno

• Un elenco aggiornato di documenti è disponibile sul sito dell’EMCDDA
• Ministero della Salute: Linee Guida di riduzione del danno; 2000.

Linee guida di prevenzione e controllo malattie infettive

• European Centre for Disease Prevention and Control (ECDC) and European Monitoring Centre for Drugs and Drug Addiction. Prevention and control of infectious diseases among people who inject drugs (EMCDDA); 2011.

Linee guida screening e test

• EMCDDA Guidelines for testing HIV, viral hepatitis and other infections in injecting drug users; 2010.
• National Hepatitis C Screening Guideline Development Group (GDG). Hepatitis C Screening National Clinical Guideline No. 15.
• Centers for Disease Control and prevention (CDC): Testing Recommendations for Hepatitis C Virus Infection.
• American Association for the Study of Liver Diseases/Infectious Diseases Society of America (AASLD/IDSA) HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection; 2019.
• Presidenza del Consiglio dei Ministri – Dipartimento Politiche Antidroga, Ministero della Salute. Nuove Linee di indirizzo per lo screening e la diagnosi delle principali patologie infettive correlate all’uso di sostanze correlate all’uso di sostanze nei Servizi per le Dipendenze; 2017.

Documenti online

• WHO: Global health sector strategy on viral hepatitis 2016 – 2021.
• EMCDDA, Health and social responses to drug problems: a European guide. Lisbon, October 2017.
• EMCDDA: Italy Country Drug Report; 2019.
• EMCDDA: Relazione europea sulla droga; 2018.
• European Liver Patients Association (ELPA). The 2016 Hep-CORE Report: Monitoring the implementation of hepatitis B and C policy recommendations in Europe.
• Relazione annuale al Parlamento sul fenomeno delle tossicodipendenze in Italia anno 2020 (dati 2019).
• Piano Nazionale per la Prevenzione delle Epatiti Virali da virus B e C (PNEV).
• WHO: Global hepatitis report 2017.

Siti web di riferimento

• World Health Organization – Hepatitis
• Associations collaborating on hepatitis to immunize and eliminate the viruses in Europe (ACHIEVE)
• Correlation – European Network Social Inclusion & Health
• HCV Can Be Cured
• Hepatitis C online
• Hepatitis Clinical Care Options
• European Initiative Hepatitis C and Drug Use (HepC)
• World Hepatitis Alliance